Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Environmental & load data: 1:15 Scale tidal turbine subject to a variety of regular wave conditions.

Draycott S, Payne GS, Steynor J, Nambiar A, Sellar B, Davey T, Noble DR, Venugopal V.

Data Brief. 2019 Mar 7;23:103732. doi: 10.1016/j.dib.2019.103732. eCollection 2019 Apr.

2.

Clathrin Adaptor Complex-interacting Protein Irc6 Functions through the Conserved C-Terminal Domain.

Zhou H, Costaguta G, Payne GS.

Sci Rep. 2019 Mar 14;9(1):4436. doi: 10.1038/s41598-019-40852-8.

3.

Clinical applications of in vivo magnetic resonance spectroscopy in oncology.

Payne GS.

Phys Med Biol. 2018 Oct 26;63(21):21TR02. doi: 10.1088/1361-6560/aae61e. Review.

PMID:
30362466
4.

Prospective multicentre evaluation and refinement of an analysis tool for magnetic resonance spectroscopy of childhood cerebellar tumours.

Manias KA, Harris LM, Davies NP, Natarajan K, MacPherson L, Foster K, Brundler MA, Hargrave DR, Payne GS, Leach MO, Morgan PS, Auer D, Jaspan T, Arvanitis TN, Grundy RG, Peet AC.

Pediatr Radiol. 2018 Oct;48(11):1630-1641. doi: 10.1007/s00247-018-4182-0. Epub 2018 Jul 30.

5.

Conserved role for Gga proteins in phosphatidylinositol 4-kinase localization to the trans-Golgi network.

Daboussi L, Costaguta G, Ghukasyan R, Payne GS.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):3433-3438. doi: 10.1073/pnas.1615163114. Epub 2017 Mar 13.

6.

Vps13 and Cdc31/centrin: Puzzling partners in membrane traffic.

Myers MD, Payne GS.

J Cell Biol. 2017 Feb;216(2):299-301. doi: 10.1083/jcb.201612026. Epub 2017 Jan 25.

7.
8.

Validating a robust double-quantum-filtered (1) H MRS lactate measurement method in high-grade brain tumours.

Payne GS, Harris LM, Cairns GS, Messiou C, deSouza NM, Macdonald A, Saran F, Leach MO.

NMR Biomed. 2016 Oct;29(10):1420-6. doi: 10.1002/nbm.3587. Epub 2016 Aug 11.

9.

Calmodulin Promotes N-BAR Domain-Mediated Membrane Constriction and Endocytosis.

Myers MD, Ryazantsev S, Hicke L, Payne GS.

Dev Cell. 2016 Apr 18;37(2):162-73. doi: 10.1016/j.devcel.2016.03.012.

10.

On the concept of sloped motion for free-floating wave energy converters.

Payne GS, Pascal R, Vaillant G.

Proc Math Phys Eng Sci. 2015 Oct 8;471(2182):20150238.

11.

Radiotherapy planning using MRI.

Schmidt MA, Payne GS.

Phys Med Biol. 2015 Nov 21;60(22):R323-61. doi: 10.1088/0031-9155/60/22/R323. Epub 2015 Oct 28.

12.

Distortion correction of echo-planar diffusion-weighted images of uterine cervix.

deSouza NM, Orton M, Downey K, Morgan VA, Collins DJ, Giles SL, Payne GS.

J Magn Reson Imaging. 2016 May;43(5):1218-23. doi: 10.1002/jmri.25080. Epub 2015 Oct 20.

13.

Determining the chemical exchange saturation transfer (CEST) behavior of citrate and spermine under in vivo conditions.

Basharat M, deSouza NM, Parkes HG, Payne GS.

Magn Reson Med. 2016 Sep;76(3):742-6. doi: 10.1002/mrm.25997. Epub 2015 Oct 15.

14.

TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.

Basharat M, Payne GS, Morgan VA, Parker C, Dearnaley D, deSouza NM.

J Magn Reson Imaging. 2015 Oct;42(4):1086-93. doi: 10.1002/jmri.24875. Epub 2015 Aug 10.

15.

Single-shot single-voxel lactate measurements using FOCI-LASER and a multiple-quantum filter.

Payne GS, deSouza NM, Messiou C, Leach MO.

NMR Biomed. 2015 Apr;28(4):496-504. doi: 10.1002/nbm.3276.

16.

Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters.

Riches SF, Payne GS, Morgan VA, Dearnaley D, Morgan S, Partridge M, Livni N, Ogden C, deSouza NM.

Eur Radiol. 2015 May;25(5):1247-56. doi: 10.1007/s00330-014-3479-0. Epub 2015 Mar 7.

PMID:
25749786
17.

Evaluation of lactate detection using selective multiple quantum coherence in phantoms and brain tumours.

Harris LM, Tunariu N, Messiou C, Hughes J, Wallace T, DeSouza NM, Leach MO, Payne GS.

NMR Biomed. 2015 Mar;28(3):338-43. doi: 10.1002/nbm.3255. Epub 2015 Jan 14.

18.

Functional MRI and CT biomarkers in oncology.

Winfield JM, Payne GS, deSouza NM.

Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):562-78. doi: 10.1007/s00259-014-2979-0. Epub 2015 Jan 13. Review.

PMID:
25578953
19.
20.

Effect on therapeutic ratio of planning a boosted radiotherapy dose to the dominant intraprostatic tumour lesion within the prostate based on multifunctional MR parameters.

Riches SF, Payne GS, Desouza NM, Dearnaley D, Morgan VA, Morgan SC, Partridge M.

Br J Radiol. 2014 May;87(1037):20130813. doi: 10.1259/bjr.20130813. Epub 2014 Mar 6.

21.

Evaluation of short-TE (1)H MRSI for quantification of metabolites in the prostate.

Basharat M, Jafar M, deSouza NM, Payne GS.

NMR Biomed. 2014 Apr;27(4):459-67. doi: 10.1002/nbm.3082. Epub 2014 Feb 12.

22.

Molecular and metabolic consequences following E6 transfection in an isogenic ovarian cell line (A2780) pair.

Chung YL, Nagy E, Zietkowski D, Payne GS, Phillips DH, deSouza NM.

Cell Physiol Biochem. 2013;32(5):1460-72.

23.

Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.

Arias-Mendoza F, Payne GS, Zakian K, Stubbs M, O'Connor OA, Mojahed H, Smith MR, Schwarz AJ, Shukla-Dave A, Howe F, Poptani H, Lee SC, Pettengel R, Schuster SJ, Cunningham D, Heerschap A, Glickson JD, Griffiths JR, Koutcher JA, Leach MO, Brown TR.

Acad Radiol. 2013 Sep;20(9):1122-9. doi: 10.1016/j.acra.2013.04.013.

24.

Clathrin, adaptors and disease: insights from the yeast Saccharomyces cerevisiae.

Myers MD, Payne GS.

Front Biosci (Landmark Ed). 2013 Jun 1;18:862-91. Review.

PMID:
23747853
25.

Characterisation of mobile lipid resonances in tissue biopsies from patients with cervical cancer and correlation with cytoplasmic lipid droplets.

Zietkowski D, deSouza NM, Davidson RL, Payne GS.

NMR Biomed. 2013 Sep;26(9):1096-102. doi: 10.1002/nbm.2923. Epub 2013 Feb 17.

PMID:
23417787
26.

Yeast Irc6p is a novel type of conserved clathrin coat accessory factor related to small G proteins.

Gorynia S, Lorenz TC, Costaguta G, Daboussi L, Cascio D, Payne GS.

Mol Biol Cell. 2012 Nov;23(22):4416-29. doi: 10.1091/mbc.E12-07-0507. Epub 2012 Sep 19.

27.

Adaptor autoregulation promotes coordinated binding within clathrin coats.

Hung CW, Aoh QL, Joglekar AP, Payne GS, Duncan MC.

J Biol Chem. 2012 May 18;287(21):17398-407. doi: 10.1074/jbc.M112.349035. Epub 2012 Mar 28.

28.

Phosphoinositide-mediated clathrin adaptor progression at the trans-Golgi network.

Daboussi L, Costaguta G, Payne GS.

Nat Cell Biol. 2012 Feb 19;14(3):239-48. doi: 10.1038/ncb2427.

29.

Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.

Beloueche-Babari M, Arunan V, Troy H, te Poele RH, te Fong AC, Jackson LE, Payne GS, Griffiths JR, Judson IR, Workman P, Leach MO, Chung YL.

Cancer Res. 2012 Feb 15;72(4):990-1000. doi: 10.1158/0008-5472.CAN-11-2688. Epub 2011 Dec 22.

30.

An evaluation of motion compensation strategies and repeatability for abdominal (1)H MR spectroscopy measurements in volunteer studies and clinical trials.

Germuska M, Tunariu N, Leach MO, Xu J, Payne GS.

NMR Biomed. 2012 Jun;25(6):859-65. doi: 10.1002/nbm.1802. Epub 2011 Dec 22.

PMID:
22190219
31.

Comparison of NMR lipid profiles in mitotic arrest and apoptosis as indicators of paclitaxel resistance in cervical cell lines.

Zietkowski D, Payne GS, Nagy E, Mobberley MA, Ryder TA, deSouza NM.

Magn Reson Med. 2012 Aug;68(2):369-77. doi: 10.1002/mrm.23265. Epub 2011 Dec 12.

32.

Noninvasive detection of carboxypeptidase G2 activity in vivo.

Jamin Y, Smyth L, Robinson SP, Poon ES, Eykyn TR, Springer CJ, Leach MO, Payne GS.

NMR Biomed. 2011 May;24(4):343-50. doi: 10.1002/nbm.1597. Epub 2010 Oct 3.

PMID:
20891022
33.

Dynamin subunit interactions revealed.

van der Bliek AM, Payne GS.

Dev Cell. 2010 May 18;18(5):687-8. doi: 10.1016/j.devcel.2010.05.001.

34.

Regulation of clathrin adaptor function in endocytosis: novel role for the SAM domain.

Di Pietro SM, Cascio D, Feliciano D, Bowie JU, Payne GS.

EMBO J. 2010 Mar 17;29(6):1033-44. doi: 10.1038/emboj.2010.5. Epub 2010 Feb 11.

35.

Detection of cancer in cervical tissue biopsies using mobile lipid resonances measured with diffusion-weighted (1)H magnetic resonance spectroscopy.

Zietkowski D, Davidson RL, Eykyn TR, De Silva SS, Desouza NM, Payne GS.

NMR Biomed. 2010 May;23(4):382-90. doi: 10.1002/nbm.1472. Epub 2009 Dec 15.

PMID:
20014336
36.

A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy.

Lee CP, Payne GS, Oregioni A, Ruddle R, Tan S, Raynaud FI, Eaton D, Campbell MJ, Cross K, Halbert G, Tracy M, McNamara J, Seddon B, Leach MO, Workman P, Judson I.

Br J Cancer. 2009 Dec 1;101(11):1860-8. doi: 10.1038/sj.bjc.6605425.

37.

MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.

Riches SF, Payne GS, Morgan VA, Sandhu S, Fisher C, Germuska M, Collins DJ, Thompson A, deSouza NM.

AJR Am J Roentgenol. 2009 Dec;193(6):1583-91. doi: 10.2214/AJR.09.2540.

PMID:
19933651
38.

Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer.

Payne GS, Schmidt M, Morgan VA, Giles S, Bridges J, Ind T, DeSouza NM.

Gynecol Oncol. 2010 Feb;116(2):246-52. doi: 10.1016/j.ygyno.2009.09.044. Epub 2009 Oct 28.

PMID:
19875159
39.

Hyperpolarized (13)C magnetic resonance detection of carboxypeptidase G2 activity.

Jamin Y, Gabellieri C, Smyth L, Reynolds S, Robinson SP, Springer CJ, Leach MO, Payne GS, Eykyn TR.

Magn Reson Med. 2009 Nov;62(5):1300-4. doi: 10.1002/mrm.22049.

40.

The effect of experimental conditions on the detection of spermine in cell extracts and tissues.

Spencer NG, Eykyn TR, deSouza NM, Payne GS.

NMR Biomed. 2010 Feb;23(2):163-9. doi: 10.1002/nbm.1438.

PMID:
19757478
41.

A novel technique to monitor carboxypeptidase G2 expression in suicide gene therapy using 19F magnetic resonance spectroscopy.

Mancini L, Davies L, Friedlos F, Falck-Miniotis M, Dzik-Jurasz AS, Springer CJ, Leach MO, Payne GS.

NMR Biomed. 2009 Jun;22(5):561-6. doi: 10.1002/nbm.1375.

PMID:
19259950
42.

Epithelial and stromal metabolite changes in the transition from cervical intraepithelial neoplasia to cervical cancer: an in vivo 1H magnetic resonance spectroscopic imaging study with ex vivo correlation.

De Silva SS, Payne GS, Morgan VA, Ind TE, Shepherd JH, Barton DP, deSouza NM.

Eur Radiol. 2009 Aug;19(8):2041-8. doi: 10.1007/s00330-009-1363-0. Epub 2009 Mar 4.

PMID:
19259678
43.

Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR.

Gabellieri C, Beloueche-Babari M, Jamin Y, Payne GS, Leach MO, Eykyn TR.

NMR Biomed. 2009 May;22(4):456-61. doi: 10.1002/nbm.1361.

PMID:
19156696
44.

Genome-wide analysis of AP-3-dependent protein transport in yeast.

Anand VC, Daboussi L, Lorenz TC, Payne GS.

Mol Biol Cell. 2009 Mar;20(5):1592-604. doi: 10.1091/mbc.E08-08-0819. Epub 2008 Dec 30.

45.

High-throughput protein extraction and immunoblotting analysis in Saccharomyces cerevisiae.

Lorenz TC, Anand VC, Payne GS.

Methods Mol Biol. 2008;457:13-27.

PMID:
19066016
46.

Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue.

De Silva SS, Payne GS, Thomas V, Carter PG, Ind TE, deSouza NM.

NMR Biomed. 2009 Feb;22(2):191-8. doi: 10.1002/nbm.1302.

PMID:
18833545
47.

Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.

deSouza NM, Riches SF, Vanas NJ, Morgan VA, Ashley SA, Fisher C, Payne GS, Parker C.

Clin Radiol. 2008 Jul;63(7):774-82. doi: 10.1016/j.crad.2008.02.001. Epub 2008 Apr 18.

PMID:
18555035
48.

The value of magnetic resonance spectroscopy in tumour imaging.

Peet AC, Arvanitis TN, Auer DP, Davies NP, Hargrave D, Howe FA, Jaspan T, Leach MO, Macarthur D, MacPherson L, Morgan PS, Natarajan K, Payne GS, Saunders D, Grundy RG; CCLG Functional Imaging Group.

Arch Dis Child. 2008 Sep;93(9):725-7. doi: 10.1136/adc.2007.125237. Epub 2008 May 7. No abstract available.

PMID:
18463122
49.

Therapeutic target metabolism observed using hyperpolarized 15N choline.

Gabellieri C, Reynolds S, Lavie A, Payne GS, Leach MO, Eykyn TR.

J Am Chem Soc. 2008 Apr 9;130(14):4598-9. doi: 10.1021/ja8001293. Epub 2008 Mar 18.

PMID:
18345678
50.

Composite synthetic lethal identification of membrane traffic inhibitors.

Duncan MC, Ho DG, Huang J, Jung ME, Payne GS.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6235-40. Epub 2007 Apr 2.

Supplemental Content

Loading ...
Support Center